Document is current
Any future updates will be listed below
-
Authors
Gonzalez-Robles, Cristina https://orcid.org/0000-0001-6809-0127
Bandmann, Oliver https://orcid.org/0000-0003-3149-0252
Schapira, Anthony H. V. https://orcid.org/0000-0002-3018-3966
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 19 June 2025
First Online: 18 July 2025
Declarations
:
: Cristina Gonzalez-Robles has received research support from the Edmond J. Safra (EJS) Foundation (EJS Accelerating Clinical Trials in Parkinson’s Disease (EJS ACT-PD) project). Oliver Bandmann has received grants from Cure Parkinson’s (OB02), the Medical Research Council (MRC)—Centre of Excellence Award (CoEN) (MR/V006525/1) and the Jon Moulton Charity Trust. He has served on the Advisory Board for ICE. Anthony HV Schapira has received grants from the MRC (UK), Cure Parkinson’s Trust, Parkinson’s UK, EU H2020 program and Aligning Science Against Parkinson’s (ASAP), MJFF, Innovate UK and consults for Capsida and Neurocrine. Anthony HV Schapira is an Editorial Board member of Neurology and Therapy. Anthony HV Schapira was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
